NATIONAL DISEASE RESEARCH INTERCHANGE: Internationally Renowned Lung Disease Expert Joins NDRI Board

Vera P. Krymskaya, PhD, MBA, FCPP, whose seminal discoveries at the University of Pennsylvania Center for Pulmonary Biology paved the way for an FDA-approved clinical treatment for the rare lung disease lymphangioleiomyomatosis (LAM) and the inherited hamartoma syndrome, tuberous sclerosis complex (TSC), was elected Feb. 2 to a three-year term on the Board of Directors of the Philadelphia-based National Disease Research Interchange (NDRI). Read More »